Actively Recruiting
Feasibility of Aerobic Exercise With Blood Flow Restriction Training in People Living With Type 2 Diabetes
Led by University of New Brunswick · Updated on 2026-01-26
60
Participants Needed
3
Research Sites
152 weeks
Total Duration
On this page
Sponsors
U
University of New Brunswick
Lead Sponsor
D
Diabetes Canada
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this trial is to learn if blood flow restriction training with treadmill walking is possible for individuals living with type 2 diabetes. It will also learn about how the blood flow restriction with treadmill walking could improve health. The main questions it aims to answer are: Is 6 weeks of treadmill walking with blood flow restriction reasonable for people with type 2 diabetes to perform? Does treadmill walking with blood flow restriction training help manage type 2 diabetes better than just treadmill walking? Researchers will compare treadmill walking with blood flow restriction to treadmill walking without blood flow restriction to see if blood flow restriction works to manage type 2 diabetes based on fitness and blood sugar levels. Participants will: Perform treadmill walking with or without blood flow restriction for 96 minutes a week for 6 weeks. Visit the lab before and after the exercise for tests and questionnaires.
CONDITIONS
Official Title
Feasibility of Aerobic Exercise With Blood Flow Restriction Training in People Living With Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with type 2 diabetes with HbA1c between 5.7% and 9.0%
- Not regularly physically active, defined as less than 150 minutes of moderate to vigorous physical activity per week
- Aged between 19 and 64 years
You will not qualify if you...
- Musculoskeletal problems that prevent exercise training
- Medications that have been unstable over the last 3 months
- Absolute contraindications to blood flow restriction such as peripheral vascular disease
- Diagnosis or treatment for low iron levels or anemia
- Diagnosis of any red blood cell-altering condition like sickle cell anemia or poikilocytosis
- Current cardiovascular disease affecting safe exercise participation
- Use of medications that interfere with accurate heart rate monitor tracking
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Exercise Metabolism and Inflammation Laboratory
Okanagan, British Columbia, Canada
Not Yet Recruiting
2
Cardiometabolic Exercise & Lifestyle Laboratory
Fredericton, New Brunswick, Canada, E3B5A3
Actively Recruiting
3
Human Performance & Health Research Laboratory
Guelph, Ontario, Canada
Actively Recruiting
Research Team
M
Martin Senechal, PhD
CONTACT
J
Jamie Burr, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here